Abstract:Introduction Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is quite common problem in men for which there is still a need for good, non-invasive but efficacious therapeutic methods. In this study we were investigating the use of laser for CP/CPPS. Objective To assess the efficacy and safety of transrectal non-ablative Erbium YAG laser for treatment of CP/CPPS. Methods This is a retrospective cohort study executed in one medical center in period from 2018 till 2023. Patients with diagnosed CP/CPPS were treated with non-ablative Erbium YAG laser. Three laser sessions (L1, L2, L3) were executed with intervals of one and three months followed by one maintenance session (L4) when effect started to fade (12-18 months after L3). The assessment of efficacy was done through the ultrasound (US) measurement of the prostate volume and US observation of the prostate vascularization. Assessment of vascularization was done with the count of visible blood vessels (VBV) and the observation of the total vascular image, considering not only the number but also the vessels size. The volume and vascularization were assessed at each of four visits (L1-L4), before the laser treatment and approx.. 15 minutes after the laser treatment. Two weeks after each treatment session patients were checked for CP/CPPS symptoms changes and possible adverse effects. Results 51 male patients with average age of 37.4 years (range 22-60) received four transrectal non-ablative Erbium YAG laser treatments. Laser energy was delivered to the multiple locations of the prostate via R11 probe with angular adapter. Parameters used were: Smooth, 7 mm spot, 3 J/cm2, 1.6 Hz, 7 stacks. Prostate volumes showed reduction immediately after the treatment at each of the sessions and these reductions were well maintained through all successive follow-ups. Volumes at L1 before and after the treatment were 19.5 ± 6.4 and 18.5 ± 5.9 cc, at L2 18.3 ± 6.0 and 17.2 ± 6.0 cc, at L3 18.2 ± 5.4 and 15.5 ± 4.9 cc and at L4 18.5 ± 7.0 and 14.9 ± 6.1 cc. VBV were counted before and after each session and showed increases as follow: L1: before 15.6 ± 4.5 and 19.6 ± 5.9 after, at L2 19.5 ± 4.7 and 24.2 ± 5.3, at L3 21.5 ± 4.3 and 26.7 ± 4.4 and at L4 20.9 ± 4,4 and 26.4 ± 4.1. At the beginning of the therapy (L1) the overall prostate vascularization was assessed as poor in 35.3% patients, as fair in 21.6%, as good in 39.2% and as very good in 3.9% patients. Improvements during the treatments and follow-ups were: L2: 7.8% poor, 15.7% fair, 37.3% good and 39.2% very good; L3: 0% poor, 6.3% fair, 27.1% good and 66.7% very good; L4: 5.6% poor, 8.3 % fair, 33.3% good and 52.8% very good. There were no adverse effects after this therapy and patients' satisfaction with the improvements was high. Conclusions Non-ablative Erbium YAG laser treatment seems to be promising new non-invasive and safe therapy for CP/CPPS showing improvement of the symptoms which are lasting at least one year. More studies are needed to additionally prove its efficacy and safety. Disclosure No.

Observation on the Safety and Efficacy of He-Ne Laser Equipment on Chronic Abacteria Prostatitis

Prostatic Calculi Influence the Antimicrobial Efficacy in Men with Chronic Bacterial Prostatitis

A Study on the Treatment of Local and Acupoint Irradiation with Low-Energy He-Ne Laser for Pulmonary Tuberculosis Cavity

Application Effect of Combined Laser Therapeutic Instrument for Prostatitis in Treatment of Patients with Prostatitis

Clinical Observation of Therapeutic Efficacy of Kangfuxin Combined with He-Ne Laser and Oxygen Blast in the Treatment of Perianal Infection

Holmium Laser Enucleation of the Prostate: Modified Two-Lobe Technique Versus Traditional Three-Lobe Technique—A Randomized Study

Clinical Observation of Qianliejiedu Capsule on the Treatment of Chronic Prostatitis

(207) Non-Ablative Erbium Yag Laser Treatment For Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Comparative Analysis of Three Surgical Instruments in the Treatment of High Critical Enucleation of Prostate

Clinical Observation of Comprehensive Treatment for Type Ⅲ A Prostatitis

Clinical Observation Tablets of Qianlie Antong in the Treatment of 69 Chronic Abacterial Prostatitis Patients

Evaluation of two micron continuous wave laser for the treatment of high-risk older patients with benign prostatic hyperplasia (report of 39 cases)

Clinical Observation on Comprehensive Treatment of 80 Cases of Chronic Type III Prostatitis by Elongated Needle, Microwave and Moritatherapy

Clinical Observation of Azithromycin Combined with Doxazosin and Qianlieanshuan in the Treatment of NIH Ⅲ Prostatitis

Clinical Study of Efficacy and Safety of Transurethral Photoselective Laser Vaporization for Benign Prostatic Hyperplasia

[Transurethral decompression and drainage with holmium laser for prostatic abscess: Analysis of clinical therapeutic effect]

Short-term Effect of 980/1470nm Diode Laser Technology on Benign Prostatic Hyperplasia

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males

Technique and efficacy of 1470 nm diode laser antegradeenucleation of the prostate for benign Prostatic hyperplasia

Clinical efficiency of 120W diode laser vaporization for benign prostate hyperplasia：report of 57 cases

Observation on the efficacy and safety of Holmium laser enucleation of the prostate (HoLEP) with preservation of the urethral mucosa from the bladder neck to the tip of the prostate for the treatment of benign prostatic hyperplasia